Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. BNP Paribas
  6. News
  7. Summary
    BNP   FR0000131104

BNP PARIBAS

(BNP)
  Report
Real-time Euronext Paris  -  04:35 2022-09-28 am EDT
43.91 EUR   -2.67%
03:15aFTSE 100 Seen Extending Losses as Budget Concerns Linger
DJ
03:05aPorsche's blockbuster IPO is no 'gamechanger' for Europe's battered markets
RE
09/27Bnp Paribas : Exane ESG Conference - 28/09/2022 - BNP Paribas Corporate Governance
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Invasive insects and climate change : Impact on the world economy

10/05/2016 | 10:14am EDT

Even more worrying, insects in general weigh greatly on agriculture by consuming around 40% of agricultural production. 'The equivalent of enough food to feed one million humans', highlights Franck Courchamp. Among the main farming nations affected by this threat, China and the United States represent the biggest risks in terms of this threat.

In terms of health, the overall cost attributed to invasive insects exceeds $6.9bn per year. These costs do not take into account malaria, for which the majority of spending is not related to an infestation but to an insect which is naturally present. Moreover, this assessment excludes the economic impact on productivity, revenue, tourism, blood supplies, individual protection measures and quality of life. Most of the estimates for health costs are a combination of direct and indirect costs which are often related to medical care.

According to the research team, greater vigilance and the implementation of response procedures for a biological invasion would help society save tens of billions of euros. These preventive measures could divide the cost of mosquito-borne diseases by at least ten.

Researchers suggest, among other measures: strategic spending in the funding of research into the assessment and prevention of invasive species, the implementation of countermeasures adapted to each threat and the support of public awareness campaigns on the risks of introducing certain species. Finally, there is a major need to develop the network of associations in order for measures to fight against these invasive species are extended on the ground.

BNP Paribas SA published this content on 05 October 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 05 October 2016 14:14:06 UTC.


© Publicnow 2016
All news about BNP PARIBAS
03:15aFTSE 100 Seen Extending Losses as Budget Concerns Linger
DJ
03:05aPorsche's blockbuster IPO is no 'gamechanger' for Europe's battered markets
RE
09/27Bnp Paribas : Exane ESG Conference - 28/09/2022 - BNP Paribas Corporate Governance
PU
09/27Bnp Paribas : Exane ESG Conference - 28/09/2022 - BNP Paribas CSR Strategy
PU
09/27Bnp Paribas : Conférence RSE Exane - 28/09/2022 - BNP Paribas CSR Strategy
PU
09/27Bnp Paribas : Conférence RSE Exane - 28/09/2022 - BNP Paribas Corporate Governance
PU
09/27Bnp Paribas : Document AMF CP. 2022E863183
PU
09/27Bnp Paribas : Communique AMF CP. CP22862986
PU
09/27Saudi Arabia's wealth fund hires banks for debut green bonds - document
RE
09/27Bnp Paribas : Communique AMF CP. CP22862990
PU
More news
Analyst Recommendations on BNP PARIBAS
More recommendations
Financials
Sales 2022 50 004 M 47 998 M 47 998 M
Net income 2022 12 619 M 12 112 M 12 112 M
Net Debt 2022 - - -
P/E ratio 2022 4,41x
Yield 2022 9,34%
Capitalization 55 648 M 53 415 M 53 415 M
Capi. / Sales 2022 1,11x
Capi. / Sales 2023 1,15x
Nbr of Employees 190 000
Free-Float 86,8%
Chart BNP PARIBAS
Duration : Period :
BNP Paribas Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BNP PARIBAS
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 20
Last Close Price 45,11 €
Average target price 66,62 €
Spread / Average Target 47,7%
EPS Revisions
Managers and Directors
Jean-Laurent Bonnafé Co-Chief Operating Officer & Director
Jean Lemierre Chairman
Bernard Gavgani Chief Information Officer
Yann Gérardin Chief Operating Officer
Nathalie Hartmann Head-Compliance
Sector and Competitors
1st jan.Capi. (M$)
BNP PARIBAS-25.77%53 415
JPMORGAN CHASE & CO.-32.56%311 340
BANK OF AMERICA CORPORATION-30.25%245 637
INDUSTRIAL & COMMERCIAL BANK OF CHINA LTD.-15.45%204 179
WELLS FARGO & COMPANY-16.57%151 836
CHINA CONSTRUCTION BANK CORPORATION-15.56%147 050